Press release
AI in Oncology Market Outlook 2034: Projected to Reach USD 7.7 Billion at a CAGR of 16.8%
Artificial intelligence (AI) is reshaping the healthcare industry, with oncology being one of its most impactful applications. The AI in oncology market is experiencing rapid growth due to its ability to analyze vast datasets, facilitate accurate diagnoses, predict disease progression, and recommend personalized treatment options.These capabilities are transforming cancer care, empowering oncologists with tools to improve patient outcomes. In 2023, the global AI in oncology market was valued at USD 1.3 billion and is projected to expand at a compound annual growth rate (CAGR) of 16.8%, reaching USD 7.7 billion by 2034.
Unlock key takeaways and conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86018
This remarkable growth reflects the increasing adoption of AI technologies in oncology practices worldwide.
Key Findings of the Market Report
The market growth is primarily driven by the rising prevalence of cancer and the rapid adoption of AI in healthcare systems globally. AI's advanced algorithms excel in identifying subtle patterns and correlations in genetic data, medical imaging, and patient information, often surpassing human accuracy. However, challenges remain, such as potential biases in AI models, which can lead to misleading conclusions. Despite these obstacles, continuous advancements in AI and its integration with oncology practices are fostering a promising outlook for the market.
Market Growth Drivers and Trends
The increasing incidence of cancer worldwide is a significant driver of the AI in oncology market. According to the World Health Organization (WHO), there were approximately 20 million new cancer cases in 2022, with 9.7 million deaths attributed to the disease. Lung, colorectal, breast, and stomach cancers are among the most common types. Contributing factors such as rising body mass index, sedentary lifestyles, and tobacco consumption highlight the urgent need for innovative diagnostic and treatment approaches. AI's precision in detecting cancer early offers a transformative solution, enabling timely intervention and improving survival rates.
Another key trend is the integration of AI with chemotherapy and other treatment modalities. For instance, AI tools such as CURATE.AI use clinical data to create personalized digital profiles for cancer patients, optimizing chemotherapy dosages. Similarly, AI models predict responses to treatment, allowing oncologists to refine therapy plans. These advancements exemplify how computational oncology is enhancing the precision and efficiency of cancer care.
Review our report to gain deeper insights and understanding - https://www.transparencymarketresearch.com/ai-in-oncology-market.html
Regional Profile
North America leads the AI in oncology market, accounting for the largest share in 2023. The region's dominance is attributed to the widespread adoption of advanced AI technologies and substantial investments in cancer research. In the United States, AI has demonstrated its potential to reduce MRI scanning times, cut costs, and improve patient outcomes. For example, Sanofi-Aventis U.S. LLC's strategic investment in Owkin, Inc. is driving advancements in predictive biomarkers for multiple cancer types. Similarly, Canadian initiatives, such as funding from the Canadian Cancer Society, are promoting AI-driven innovations for early detection and treatment.
Europe and Asia-Pacific are also emerging as significant players in the market. Countries such as Germany, the United Kingdom, China, and India are increasing their focus on AI applications in oncology. Collaborative projects and government initiatives to integrate AI into healthcare systems are further accelerating the adoption of AI-driven cancer care in these regions.
Competitive Landscape
The competitive landscape of the AI in oncology market is characterized by innovation, strategic partnerships, and new product launches. Leading companies, including Paige.AI, Tempus, Ibex Medical Analytics, and PathAI, are developing AI-powered tools to revolutionize cancer diagnosis and treatment. For instance, Medtronic's GI Genius intelligent endoscopy module is enhancing colorectal cancer detection through improved visualization during colonoscopies.
Recent developments include Qritive's QAi Prostate tool for prostate cancer diagnosis and MedCognetics' AI-enabled software for breast cancer screening. These innovations highlight the ongoing commitment of industry players to leverage AI for improving cancer care.
Product Portfolio
AI applications in oncology span a wide range of cancer types and functions. From lung and breast cancer to colorectal and ovarian cancers, AI tools are instrumental in early diagnosis, treatment selection, drug discovery, and patient management. These applications enable oncologists to make data-driven decisions, reducing errors and enhancing the effectiveness of care. AI-based decision support systems consider factors such as a patient's genomic profile, tumor responses, and prior treatments, providing personalized recommendations for therapy regimens.
Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86018
Key Segments
The market segmentation includes cancer types such as lung, breast, colorectal, ovarian, and others, and applications such as diagnosis, treatment selection, drug discovery, and patient management. Hospitals, cancer specialty clinics, and research institutes are among the primary end-users driving demand for AI-based oncology solutions. Regional analysis indicates robust growth in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Explore Latest Research Reports by Transparency Market Research:
Plantar Fasciitis Treatment Market - https://www.transparencymarketresearch.com/plantar-fasciitis-market.html
Blood Pressure Cuffs Market - https://www.transparencymarketresearch.com/blood-pressure-cuffs-market.html
Vaginal Slings Market - https://www.transparencymarketresearch.com/vaginal-slings-market.html
Stretcher Chairs Market - https://www.transparencymarketresearch.com/stretcher-chairs-market-2018-2026.html
Plasma Fractionation Market - https://www.transparencymarketresearch.com/plasma-fractionation-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Oncology Market Outlook 2034: Projected to Reach USD 7.7 Billion at a CAGR of 16.8% here
News-ID: 3820716 • Views: …
More Releases from Transparency Market Research

Point-of-Care Glucose Testing Market: Technological Innovations Shaping the Futu …
The global healthcare industry is undergoing a technological revolution, and Point-of-Care (POC) glucose testing is at the forefront of this transformation. As diabetes continues to impact millions of lives worldwide, the need for efficient, accurate, and timely glucose monitoring has become critical.
Newly released data from Transparency Market Research reveals that the global POC glucose testing market was valued at USD 3.7 billion in 2021 and is expected to reach USD…

Dental Dust Collector Market: Regional Insights and Forecasts to 2031
The dental dust collector market has been witnessing significant growth as the dental industry places a greater emphasis on occupational safety and adopts advanced technology.
Dental dust collectors play a crucial role in creating a clean and safe environment in dental clinics and laboratories by capturing harmful airborne particles produced during procedures such as drilling, grinding, and polishing.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85310
These devices…

Vacuum Insulation Panels Market Size Will Anticipated to Reach US$ 12.6 Billion, …
The vacuum insulation panels (VIPs) market represents a vital component in the global push for energy efficiency and thermal insulation solutions. VIPs are advanced thermal insulating materials that offer superior performance compared to traditional insulation products. These panels, composed of a core material enclosed within a gas-tight envelope, are widely used across industries, including construction, refrigeration, and logistics, where high thermal resistance is critical.
It is estimated to grow at a…

Aviation Lubricants Market Outlook 2031: Expanding from US$ 991.8 Million to US$ …
The aviation lubricants market is a crucial segment within the aerospace industry, encompassing specialized oils, greases, and fluids designed to enhance the performance and reliability of aircraft systems. These lubricants are essential for ensuring operational efficiency, reducing wear and tear, and maintaining safety standards across commercial, military, and general aviation sectors.
It is estimated to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 1.6 Bn by…
More Releases for Oncology
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications.
The research goes into great detail on several aspects that have been studied as…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland and…
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland and…
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland and…
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated…